Click on each image below to explore the studies I’ve worked on.
The RADAR study is a UK-based Phase 2/3 clinical trial investigating risk-adapted and response-guided treatment strategies for newly diagnosed multiple myeloma patients eligible for stem cell transplantation. It examines how genetic risk factors and minimal residual disease (MRD) status can inform tailored treatment approaches, including the use of standard therapies and the novel immunotherapy isatuximab.
At our hospital, I contributed to this complex study primarily through meticulous data collection, ensuring the integrity of information critical to evaluating these personalized treatment strategies. Engaging with such an intricate trial has deepened my appreciation for the role of precision medicine in oncology.
The UK Adult ITP Registry is a national research initiative collecting comprehensive clinical data on adults with primary immune thrombocytopenia (ITP), a rare autoimmune disorder characterized by low platelet counts and increased bleeding risk. By analysing patient information, the registry aims to enhance understanding of ITP's epidemiology, treatment responses, and long-term outcomes, including management during pregnancy .
At our hospital, I contributed to this study through meticulous data collection, ensuring the accuracy and completeness of patient records. Engaging with this registry has deepened my appreciation for the complexities of rare hematological conditions and the importance of robust data in informing clinical practice.
The CITRuS study is a feasibility trial exploring the use of electronic patient-reported outcome measures (ePROMs) to monitor and manage symptoms in colorectal cancer patients undergoing surgery or radiotherapy. By enabling patients to regularly report their symptoms online, the study aims to identify and address treatment-related side effects more promptly, improving patient care and quality of life.
As a Trial Facilitator, I supported the study set-up at our site, reviewed protocol documents and amendments, and oversaw the study’s closure locally. It was a valuable experience in coordinating trial logistics and ensuring regulatory compliance in a digitally enhanced research setting.